CERC-501

J&J beefs up neuro pipeline, bags a new depression drug from Cerecor in $45M deal
Endpoints
Mon, 08/14/17 - 10:33 am
JNJ
Cerecor
CERC-501
clinical depression
Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater
Endpoints
Wed, 11/30/16 - 09:58 am
Cerecor
clinical depression
clinical trials
CERC-501
Eli Lilly
Alkermes